4.8 Article

PCSK9 Impedes Hepatitis C Virus Infection In Vitro and Modulates Liver CD81 Expression

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

Vera Rocha-Perugini et al.

PLOS ONE (2008)

Article Biochemical Research Methods

Structural characterization of recombinant human CD81 produced in Pichia pastoris

Mohammed Jamshad et al.

PROTEIN EXPRESSION AND PURIFICATION (2008)

Article Biochemistry & Molecular Biology

Plasma PCSK9 levels correlate with cholesterol in men but not in women

Janice Mayne et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Biochemistry & Molecular Biology

Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity

Jun Li et al.

BIOCHEMICAL JOURNAL (2007)

Article Biochemistry & Molecular Biology

Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells

Markey C. McNutt et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Genetics & Heredity

The proprotein convertases are potential targets in the treatment of dyslipidemia

Nabil G. Seidah et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2007)

Article Medicine, Research & Experimental

Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice

Thomas A. Lagace et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Gastroenterology & Hepatology

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment

Kavitha Gopal et al.

HEPATOLOGY (2006)

Review Virology

Cell entry of hepatitis C virus

B Bartosch et al.

VIROLOGY (2006)

Article Biochemistry & Molecular Biology

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes

D Lavillette et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Biochemistry & Molecular Biology

How does hepatitis C virus enter cells?

Gundo Diedrich

FEBS JOURNAL (2006)

Article Genetics & Heredity

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote

Zhenze Zhao et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2006)

Article Gastroenterology & Hepatology

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

P Simmonds et al.

HEPATOLOGY (2005)

Article Multidisciplinary Sciences

Complete replication of hepatitis C virus in cell culture

BD Lindenbach et al.

SCIENCE (2005)

Article Multidisciplinary Sciences

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

S Rashid et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Infectious Diseases

Hepatitis C virus infection

BJ Thomson et al.

CLINICAL MICROBIOLOGY AND INFECTION (2005)

Article Multidisciplinary Sciences

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

KN Maxwell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Medicine, General & Internal

Viral hepatitis C

T Poynard et al.

LANCET (2003)

Article Genetics & Heredity

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

M Abifadel et al.

NATURE GENETICS (2003)

Article Multidisciplinary Sciences

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):: Liver regeneration and neuronal differentiation

NG Seidah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

E Scarselli et al.

EMBO JOURNAL (2002)